The article " Why Wall Street Gave Up on Pfizer—and Why That May Be a Mistake " first appeared on MarketBeat.

Pfizer has received a tax demand order amounting to Rs 8.79 crore, including penalty, from the Office of the Additional ...

This makes Pfizer a potentially cheap stock to buy while collecting a solid dividend. It's generated about $14 billion in ...

Depo Provera’s label change comes amidst a flurry of over 2,000 lawsuits from women alleging that the contraceptive caused their meningiomas.

Editorial: Over the holiday period, the Guardian leader column is looking ahead at the themes of 2026. Today we examine how the White House’s war on vaccines has left the future of a key technology un ...

Welcome to this week's Chutes & Ladders, our roundup of significant leadership hirings, firings and retirings across the ...

The final report, presented to New York Governor Kathy Hochul, outlines a path to translate investments in the state's biotech ecosystem into real-world outcomes. -- Executives from The Michael J. Fox ...

Adaptive Biotechnologies said on Monday it has signed two non-exclusive deals with Pfizer to support research in rheumatoid arthritis and other immune-related diseases. Shares of Adaptive were up over ...

Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and ...

The Ninth Circuit shut down Elizabeth Holmes's appeal, affirming fraud convictions and a $452 million restitution order for ...

With President Donald Trump back in the White House in 2025, it’s no surprise that he dominates the FactCheck.org year-end ...

A recent randomised controlled trial showed that proton pump inhibitors (PPIs), compared with histamine-2 receptor antagonists (H2RAs), induce greater gut microbiome alterations and oral-to-gut ...